World Pharma Newsfeed
Viagra against heart failure
How sildenafil, the active ingredient in Viagra, can alleviate heart problems is reported by Bochum's researchers in coo...
First-of-its-kind endovascular trial of the investigational Esprit(TM) therapy
Abbott (NYSE: ABT) announced the initiation of ESPRIT I, a first-of-its-kind clinical trial in Europe evaluating the saf...
GlaxoSmithKline provides update on divestment of non-core over-the-counter (OTC) brands
GSK has reached agreement to divest the previously identified non-core OTC brands in the United States and Canada to Pre...
NIH scientists find a potential new avenue for cancer therapies
Recent findings in mice suggest that blocking the production of small molecules produced in the body, known as epoxyeico...
AstraZeneca updates on olaparib and TC-5214 development programmes
AstraZeneca announced that its investigational compound olaparib will not progress into Phase III development for the ma...
Four potential blockbusters in the Pharma pipeline
The Bayer Group plans to continue investing heavily in research and development and expects its Pharmaceuticals business...
Amgen and Watson Announce Collaboration to Develop and Commercialize Oncology Biosimilars
Amgen (NASDAQ:AMGN) and Watson Pharmaceuticals, Inc. (NYSE:WPI) announced that they will collaborate to develop and comm...
Prevent Pneumococcal Disease in Infants and Young Children in the World's Poorest Countries
Pfizer Inc. (NYSE:PFE) has entered into a second supply agreement which will broaden and extend the duration of the Comp...
A gene that protects against colorectal cancers
The research team at Lyon has developed an animal model carrying a mutation of the DCC gene. Mice carrying the mutation ...
New light on medicinal benefits of plants
Scientists are about to make publicly available all the data they have so far on the genetic blueprint of medicinal plan...
